Lifecore Biomedical Inc’s filing revealed that its 10% Owner English Aron R. unloaded Company’s shares for reported $7.41 million on May 27 ’25. In the deal valued at $6.50 per share,1,139,504 shares were sold. As a result of this transaction, English Aron R. now holds 414,599 shares worth roughly $2.82 million.
Then, English Aron R. sold 150,419 shares, generating $1,071,555 in total proceeds. Upon selling the shares at $7.12, the 10% Owner now owns 264,180 shares.
Before that, English Aron R. sold 96,137 shares. Lifecore Biomedical Inc shares valued at $649,386 were divested by the 10% Owner at a price of $6.75 per share. As a result of the transaction, English Aron R. now holds 1,554,103 shares, worth roughly $10.58 million.
William Blair initiated its Lifecore Biomedical Inc [LFCR] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who began to cover the stock in early September with a ‘”a Buy”‘ rating. Barrington Research also remained covering LFCR and has decreased its forecast on August 28, 2024 with a “Mkt perform” recommendation from previously “an Outperform” rating. Stephens revised its rating on March 20, 2023. It rated LFCR as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of LFCR
On Tuesday, Lifecore Biomedical Inc [NASDAQ:LFCR] saw its stock jump 2.10% to $6.81. Over the last five days, the stock has lost -0.73%. Lifecore Biomedical Inc shares have fallen nearly -8.34% since the year began. Nevertheless, the stocks have risen 29.22% over the past one year. While a 52-week high of $7.99 was reached on 01/03/25, a 52-week low of $3.68 was recorded on 04/07/25.
Levels Of Support And Resistance For LFCR Stock
The 24-hour chart illustrates a support level at 6.72, which if violated will result in even more drops to 6.64. On the upside, there is a resistance level at 6.91. A further resistance level may holdings at 7.01.
